FOLR2 and atherosclerosis: In another study utilizing folate-functionalized PEG-coated liposomes to target FR-β positive macrophages in atherosclerosis mice [27], the biodistribution visualized using fluorescence demonstrated that the folate-functionalized liposomes primarily accumulated in the inflamed aorta/heart region up to 4 days post intraperitoneal administration.